Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-19-004093
Filing Date
2019-07-29
Accepted
2019-07-29 20:00:44
Documents
1
Period of Report
2019-07-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 5319
  Complete submission text file 0001562180-19-004093.txt   6664
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
Cloonan Michael (Reporting) CIK: 0001704336 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36544 | Film No.: 19982908